Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13, 89–102 (2012).
Ballar Kirmizibayrak, P., Erbaykent-Tepedelen, B., Gozen, O. & Erzurumlu, Y. Divergent modulation of proteostasis in prostate cancer. Adv. Exp. Med. Biol. 1233, 117–151 (2020).
Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8, 519–529 (2007).
Hsu, S. K. et al. Unfolded protein response (UPR) in survival, dormancy, immunosuppression, metastasis, and treatments of cancer cells. Int. J. Mol. Sci. https://doi.org/10.3390/ijms20102518 (2019).
Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).
Schweizer, M. T. & Yu, E. Y. Persistent androgen receptor addiction in castration-resistant prostate cancer. J. Hematol. Oncol. 8, 128 (2015).
Nguyen, H. G. et al. Development of a stress response therapy targeting aggressive prostate cancer. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aar2036 (2018).
Jin, Y. & Saatcioglu, F. Targeting the unfolded protein response in hormone-regulated cancers. Trends Cancer 6, 160–171 (2020).
Schwarz, D. S. & Blower, M. D. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol. Life Sci. 73, 79–94 (2016).
Fagone, P. & Jackowski, S. Membrane phospholipid synthesis and endoplasmic reticulum function. J. Lipid Res. 50 (Suppl.), S311–S316 (2009).
Hudson, D. A., Gannon, S. A. & Thorpe, C. Oxidative protein folding: from thiol-disulfide exchange reactions to the redox poise of the endoplasmic reticulum. Free Radic. Biol. Med. 80, 171–182 (2015).
Hwang, C., Sinskey, A. J. & Lodish, H. F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257, 1496–1502 (1992).
Barlowe, C. K. & Miller, E. A. Secretory protein biogenesis and traffic in the early secretory pathway. Genetics 193, 383–410 (2013).
Stephens, S. B. & Nicchitta, C. V. Divergent regulation of protein synthesis in the cytosol and endoplasmic reticulum compartments of mammalian cells. Mol. Biol. Cell 19, 623–632 (2008).
Braakman, I. & Hebert, D. N. Protein folding in the endoplasmic reticulum. Cold Spring Harb. Perspect. Biol. 5, a013201 (2013).
Xu, C., Bailly-Maitre, B. & Reed, J. C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656–2664 (2005).
Sitia, R. & Braakman, I. Quality control in the endoplasmic reticulum protein factory. Nature 426, 891–894 (2003).
Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081–1086 (2011).
Limia, C. M. et al. Emerging roles of the endoplasmic reticulum associated unfolded protein response in cancer cell migration and invasion. Cancers https://doi.org/10.3390/cancers11050631 (2019).
Ellgaard, L. & Helenius, A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181–191 (2003).
Lin, J. H., Walter, P. & Yen, T. S. Endoplasmic reticulum stress in disease pathogenesis. Annu. Rev. Pathol. 3, 399–425 (2008).
Schonthal, A. H. Endoplasmic reticulum stress: its role in disease and novel prospects for therapy. Scientifica 2012, 857516 (2012).
Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H. & Ron, D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5, 897–904 (2000).
Gardner, B. M. & Walter, P. Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response. Science 333, 1891–1894 (2011).
Tam, A. B. et al. The UPR activator ATF6 responds to proteotoxic and lipotoxic stress by distinct mechanisms. Dev. Cell 46, 327–343.e327 (2018).
Carrara, M., Prischi, F. & Ali, M. M. UPR signal activation by luminal sensor domains. Int. J. Mol. Sci. 14, 6454–6466 (2013).
Tabas, I. & Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184–190 (2011).
Cox, J. S., Shamu, C. E. & Walter, P. Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 73, 1197–1206 (1993).
Adams, C. J., Kopp, M. C., Larburu, N., Nowak, P. R. & Ali, M. M. U. Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1. Front. Mol. Biosci. 6, 11 (2019).
Meusser, B., Hirsch, C., Jarosch, E. & Sommer, T. ERAD: the long road to destruction. Nat. Cell Biol. 7, 766–772 (2005).
Maurel, M., Chevet, E., Tavernier, J. & Gerlo, S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39, 245–254 (2014).
Zhang, L., Chen, J. & Fu, H. Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc. Natl Acad. Sci. USA 96, 8511–8515 (1999).
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P. & Ron, D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2, 326–332 (2000).
Proud, C. G. eIF2 and the control of cell physiology. Semin. Cell Dev. Biol. 16, 3–12 (2005).
Wek, R. C., Jiang, H. Y. & Anthony, T. G. Coping with stress: eIF2 kinases and translational control. Biochem. Soc. Trans. 34, 7–11 (2006).
Palam, L. R., Baird, T. D. & Wek, R. C. Phosphorylation of eIF2 facilitates ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation. J. Biol. Chem. 286, 10939–10949 (2011).
Vattem, K. M. & Wek, R. C. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl Acad. Sci. USA 101, 11269–11274 (2004).
Tsuru, A., Imai, Y., Saito, M. & Kohno, K. Novel mechanism of enhancing IRE1alpha-XBP1 signalling via the PERK-ATF4 pathway. Sci. Rep. 6, 24217 (2016).
Iurlaro, R. & Munoz-Pinedo, C. Cell death induced by endoplasmic reticulum stress. FEBS J. 283, 2640–2652 (2016).
Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374–1395 (2016).
Denoyelle, C. et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat. Cell Biol. 8, 1053–1063 (2006).
Hart, L. S. et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J. Clin. Invest. 122, 4621–4634 (2012).
Hai, T. W., Liu, F., Coukos, W. J. & Green, M. R. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3, 2083–2090 (1989).
Shen, J., Chen, X., Hendershot, L. & Prywes, R. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99–111 (2002).
Nadanaka, S., Okada, T., Yoshida, H. & Mori, K. Role of disulfide bridges formed in the luminal domain of ATF6 in sensing endoplasmic reticulum stress. Mol. Cell Biol. 27, 1027–1043 (2007).
Ni, M. & Lee, A. S. ER chaperones in mammalian development and human diseases. FEBS Lett. 581, 3641–3651 (2007).
Luo, B. & Lee, A. S. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32, 805–818 (2013).
Krebs, J., Agellon, L. B. & Michalak, M. Ca2+ homeostasis and endoplasmic reticulum (ER) stress: an integrated view of calcium signaling. Biochem. Biophys. Res. Commun. 460, 114–121 (2015).
Berridge, M. J., Lipp, P. & Bootman, M. D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11–21 (2000).
Lievremont, J. P., Rizzuto, R., Hendershot, L. & Meldolesi, J. BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+. J. Biol. Chem. 272, 30873–30879 (1997).
Roderick, H. L., Lechleiter, J. D. & Camacho, P. Cytosolic phosphorylation of calnexin controls intracellular Ca2+ oscillations via an interaction with SERCA2b. J. Cell Biol. 149, 1235–1248 (2000).
Carreras-Sureda, A., Pihan, P. & Hetz, C. Calcium signaling at the endoplasmic reticulum: fine-tuning stress responses. Cell Calcium 70, 24–31 (2018).
John, L. M., Lechleiter, J. D. & Camacho, P. Differential modulation of SERCA2 isoforms by calreticulin. J. Cell Biol. 142, 963–973 (1998).
Cardenas, C. et al. Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142, 270–283 (2010).
Pinton, P. & Rizzuto, R. Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ. 13, 1409–1418 (2006).
Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85–95 (2011).
Galluzzi, L., Yamazaki, T. & Kroemer, G. Linking cellular stress responses to systemic homeostasis. Nat. Rev. Mol. Cell Biol. 19, 731–745 (2018).
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).
NCCN. Prostate Cancer NCCN Evidence Blocks. NCCN https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf (2022).
NCCN. NCCN Guidelines Version 1.2020 Prostate Cancer. NCCN https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf (2020).
Storm, M., Sheng, X., Arnoldussen, Y. J. & Saatcioglu, F. Prostate cancer and the unfolded protein response. Oncotarget 7, 54051–54066 (2016).
Madden, E., Logue, S. E., Healy, S. J., Manie, S. & Samali, A. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol. Cell 111, 1–17 (2019).
Moenner, M., Pluquet, O., Bouchecareilh, M. & Chevet, E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 67, 10631–10634 (2007).
Koumenis, C. & Wouters, B. G. “Translating” tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol. Cancer Res. 4, 423–436 (2006).
Romero-Ramirez, L. et al. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64, 5943–5947 (2004).
Blais, J. D. et al. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Mol. Cell Biol. 26, 9517–9532 (2006).
Bi, M. et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24, 3470–3481 (2005).
Weidemann, A. & Johnson, R. S. Biology of HIF-1α. Cell Death Differ. 15, 621–627 (2008).
Chen, X. et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway. Nature 508, 103–107 (2014).
Vergis, R. et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol. 9, 342–351 (2008).
Ivanova, I. G., Park, C. V., Yemm, A. I. & Kenneth, N. S. PERK/eIF2α signaling inhibits HIF-induced gene expression during the unfolded protein response via YB1-dependent regulation of HIF1α translation. Nucleic Acids Res. 46, 3878–3890 (2018).
Jamaspishvili, T. et al. Clinical implications of PTEN loss in prostate cancer. Nat. Rev. Urol. 15, 222–234 (2018).
Faisal, F. A. & Lotan, T. L. The genomic and molecular pathology of prostate cancer: clinical implications for diagnosis, prognosis, and therapy. Adv. Anat. Pathol. 27, 11–19 (2020).
Kim, J., Eltoum, I. E., Roh, M., Wang, J. & Abdulkadir, S. A. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer. PLoS Genet. 5, e1000542 (2009).
Ruggero, D. The role of Myc-induced protein synthesis in cancer. Cancer Res. 69, 8839–8843 (2009).
Pallmann, N. et al. Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer. Oncogene 38, 6301–6318 (2019).
Sheng, X. et al. Divergent androgen regulation of unfolded protein response pathways drives prostate cancer. EMBO Mol. Med. 7, 788–801 (2015).
Rouschop, K. M. et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 120, 127–141 (2010).
Huang, Y. L. et al. Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells. Cell Signal. 26, 611–618 (2014).
Zhao, R. et al. ATF6α promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis. Prostate 82, 617–629 (2022).
Mahadevan, N. R. et al. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells. Proc. Natl Acad. Sci. USA 108, 6561–6566 (2011).
Rodvold, J. J. et al. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Sci. Signal. https://doi.org/10.1126/scisignal.aah7177 (2017).
Direito, I., Fardilha, M. & Helguero, L. A. Contribution of the unfolded protein response to breast and prostate tissue homeostasis and its significance to cancer endocrine response. Carcinogenesis 40, 203–215 (2019).
Lee, A. S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 67, 3496–3499 (2007).
Daneshmand, S. et al. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. Hum. Pathol. 38, 1547–1552 (2007).
Pootrakul, L. et al. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin. Cancer Res. 12, 5987–5993 (2006).
Maddalo, D. et al. A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death. PLoS ONE 7, e45690 (2012).
Liu, R. et al. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin. Cancer Res. 19, 6802–6811 (2013).
Fu, Y. et al. Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium. Proc. Natl Acad. Sci. USA 105, 19444–19449 (2008).
Zhang, Y. et al. Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PLoS ONE 8, e80071 (2013).
Liu, P., Cheng, H., Roberts, T. M. & Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627–644 (2009).
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
Binet, F. & Sapieha, P. ER stress and angiogenesis. Cell Metab. 22, 560–575 (2015).
Ghosh, R. et al. Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS ONE 5, e9575 (2010).
Dong, D. et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res. 68, 498–505 (2008).
Taghizadeh, S. et al. sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis. BMC Mol. Cell Biol. 22, 30 (2021).
Fang, J., Ding, M., Yang, L., Liu, L. Z. & Jiang, B. H. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal. 19, 2487–2497 (2007).
Murakami, T. et al. Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J. Neurochem. 96, 1090–1100 (2006).
Mellor, P. et al. CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis. Mol. Cell Biol. 33, 4985–4995 (2013).
Dhingra, P. et al. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. Genome Biol. 18, 141 (2017).
Prakash, O., Gill, J. & Farr, G. Immune disorders and susceptibility to neoplasms. Ochsner J. 4, 107–111 (2002).
Zanetti, M., Xian, S., Dosset, M. & Carter, H. The unfolded protein response at the tumor-immune interface. Front. Immunol. 13, 823157 (2022).
Cubillos-Ruiz, J. R. et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161, 1527–1538 (2015).
Cubillos-Ruiz, J. R., Bettigole, S. E. & Glimcher, L. H. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell 168, 692–706 (2017).
Hilligan, K. L. & Ronchese, F. Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses. Cell Mol. Immunol. 17, 587–599 (2020).
Mahadevan, N. R., Fernandez, A., Rodvold, J. J., Almanza, G. & Zanetti, M. Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. J. Inflamm. Res. 3, 99–103 (2010).
Phan, T. G. & Croucher, P. I. The dormant cancer cell life cycle. Nat. Rev. Cancer 20, 398–411 (2020).
Paez, D. et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin. Cancer Res. 18, 645–653 (2012).
Ranganathan, A. C., Zhang, L., Adam, A. P. & Aguirre-Ghiso, J. A. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 66, 1702–1711 (2006).
Ranganathan, A. C., Ojha, S., Kourtidis, A., Conklin, D. S. & Aguirre-Ghiso, J. A. Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival. Cancer Res. 68, 3260–3268 (2008).
Ranganathan, A. C., Adam, A. P., Zhang, L. & Aguirre-Ghiso, J. A. Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells. Cancer Biol. Ther. 5, 729–735 (2006).
Amling, C. L. et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J. Urol. 164, 101–105 (2000).
Morrissey, C., Vessella, R. L., Lange, P. H. & Lam, H. M. The biology and clinical implications of prostate cancer dormancy and metastasis. J. Mol. Med. 94, 259–265 (2016).
Sekino, Y. & Teishima, J. Molecular mechanisms of docetaxel resistance in prostate cancer. Cancer Drug Resist. 3, 676–685 (2020).
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal. Transduct. Target. Ther. 5, 28 (2020).
Zhu, H. et al. Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients. PLoS ONE 9, e103882 (2014).
Shiota, M. et al. Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer. Cancer Res. 73, 3109–3119 (2013).
Voll, E. A. et al. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget 5, 2648–2663 (2014).
Rzymski, T. et al. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene 31, 3621–3634 (2012).
Xiao, L. J. et al. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int. J. Oncol. 40, 1714–1724 (2012).
Ward, A. K. et al. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers. Breast Cancer Res. 18, 12 (2016).
Feng, Y. X. et al. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nat. Commun. 8, 1079 (2017).
Avivar-Valderas, A. et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol. Cell Biol. 31, 3616–3629 (2011).
Mao, C., Livezey, M., Kim, J. E. & Shapiro, D. J. Antiestrogen resistant cell lines expressing estrogen receptor α mutations upregulate the unfolded protein response and are killed by BHPI. Sci. Rep. 6, 34753 (2016).
Shapiro, D. J., Livezey, M., Yu, L., Zheng, X. & Andruska, N. Anticipatory UPR activation: a protective pathway and target in cancer. Trends Endocrinol. Metab. 27, 731–741 (2016).
Zhao, N. et al. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J. Clin. Invest. 128, 1283–1299 (2018).
Zhou, Y., Bolton, E. C. & Jones, J. O. Androgens and androgen receptor signaling in prostate tumorigenesis. J. Mol. Endocrinol. 54, R15–R29 (2015).
Aurilio, G. et al. Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications. Cells https://doi.org/10.3390/cells9122653 (2020).
Zhang, T., Karsh, L. I., Nissenblatt, M. J. & Canfield, S. E. Androgen receptor splice variant, AR-V7, as a biomarker of resistance to androgen axis-targeted therapies in advanced prostate cancer. Clin. Genitourin. Cancer 18, 1–10 (2020).
Karantanos, T., Corn, P. G. & Thompson, T. C. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches. Oncogene 32, 5501–5511 (2013).
Thorpe, J. A. & Schwarze, S. R. IRE1α controls cyclin A1 expression and promotes cell proliferation through XBP-1. Cell Stress Chaperones 15, 497–508 (2010).
Lonergan, P. E. & Tindall, D. J. Androgen receptor signaling in prostate cancer development and progression. J. Carcinog. 10, 20 (2011).
Sheng, X. et al. IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling. Nat. Commun. 10, 323 (2019).
Erzurumlu, Y. & Ballar, P. Androgen mediated regulation of endoplasmic reticulum-associated degradation and its effects on prostate cancer. Sci. Rep. 7, 40719 (2017).
Yang, F., Yuan, C., Wu, D., Zhang, J. & Zhou, X. IRE1α expedites the progression of castration-resistant prostate cancers via the positive feedback loop of IRE1α/IL-6/AR. Front. Oncol. 11, 671141 (2021).
Stelloo, S. et al. Androgen modulation of XBP1 is functionally driving part of the AR transcriptional program. Endocr. Relat. Cancer 27, 67–79 (2020).
Bai, S. et al. A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer. Oncogene 38, 4977–4989 (2019).
Wang, Q. et al. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Res. 71, 7525–7536 (2011).
Jin, Y. et al. STAMP2 increases oxidative stress and is critical for prostate cancer. EMBO Mol. Med. 7, 315–331 (2015).
Overcash, R. F. et al. Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the alpha subunit of the translation initiation factor 2. PLoS ONE 8, e55257 (2013).
Petiwala, S. M. et al. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo. Carcinogenesis 37, 827–838 (2016).
Li, G. et al. Gartanin, an isoprenylated xanthone from the mangosteen fruit (Garcinia mangostana), is an androgen receptor degradation enhancer. Mol. Nutr. Food Res. 60, 1458–1469 (2016).
Wadosky, K. M., Shourideh, M., Goodrich, D. W. & Koochekpour, S. Riluzole induces AR degradation via endoplasmic reticulum stress pathway in androgen-dependent and castration-resistant prostate cancer cells. Prostate 79, 140–150 (2019).
Li, X. et al. Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer. NPJ Breast Cancer 8, 2 (2022).
Pachikov, A. N. et al. The non-canonical mechanism of ER stress-mediated progression of prostate cancer. J. Exp. Clin. Cancer Res. 40, 289 (2021).
Sreenath, T. L. et al. ETS related gene mediated androgen receptor aggregation and endoplasmic reticulum stress in prostate cancer development. Sci. Rep. 7, 1109 (2017).
Liu, J. et al. Activation of UPR signaling pathway is associated with the malignant progression and poor prognosis in prostate cancer. Prostate 77, 274–281 (2017).
So, A. Y., de la Fuente, E., Walter, P., Shuman, M. & Bernales, S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 28, 219–223 (2009).
Yang, J. et al. Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis 4, e158 (2015).
Ahn, H. K., Lee, Y. H. & Koo, K. C. Current status and application of metformin for prostate cancer: a comprehensive review. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21228540 (2020).
Chen, C. et al. Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway. Cancer Cell Int. 21, 404 (2021).
Vinceti, M. et al. Selenium for preventing cancer. Cochrane Database Syst. Rev. 1, CD005195 (2018).
Sayehmiri, K., Azami, M., Mohammadi, Y., Soleymani, A. & Tardeh, Z. The association between selenium and prostate cancer: a systematic review and meta-analysis. Asian Pac. J. Cancer Prev. 19, 1431–1437 (2018).
Klein, E. A. et al. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 306, 1549–1556 (2011).
Wu, Y., Zhang, H., Dong, Y., Park, Y. M. & Ip, C. Endoplasmic reticulum stress signal mediators are targets of selenium action. Cancer Res. 65, 9073–9079 (2005).
Zu, K. et al. Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells. Oncogene 25, 546–554 (2006).
Skrott, Z. et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature 552, 194–199 (2017).
Majera, D. et al. Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. Prostate 79, 352–362 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02671890 (2022).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT04521335 (2022).
Sehgal, P. et al. Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response. J. Biol. Chem. 292, 19656–19673 (2017).
Lindner, P., Christensen, S. B., Nissen, P., Moller, J. V. & Engedal, N. Cell death induced by the ER stressor thapsigargin involves death receptor 5, a non-autophagic function of MAP1LC3B, and distinct contributions from unfolded protein response components. Cell Commun. Signal. 18, 12 (2020).
Aloysius, H. & Hu, L. Targeted prodrug approaches for hormone refractory prostate cancer. Med. Res. Rev. 35, 554–585 (2015).
Denmeade, S. R. et al. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. J. Natl Cancer Inst. 95, 990–1000 (2003).
Shiraishi, T. et al. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res. 65, 6364–6370 (2005).
Guha, P., Kaptan, E., Gade, P., Kalvakolanu, D. V. & Ahmed, H. Tunicamycin induced endoplasmic reticulum stress promotes apoptosis of prostate cancer cells by activating mTORC1. Oncotarget 8, 68191–68207 (2017).
Hetz, C., Axten, J. M. & Patterson, J. B. Pharmacological targeting of the unfolded protein response for disease intervention. Nat. Chem. Biol. 15, 764–775 (2019).
Lu, T. et al. Knockdown of glucose-regulated protein 78/binding immunoglobulin heavy chain protein expression by asymmetric small interfering RNA induces apoptosis in prostate cancer cells and attenuates migratory capability. Mol. Med. Rep. 11, 249–256 (2015).
Backer, J. M. et al. Chaperone-targeting cytotoxin and endoplasmic reticulum stress-inducing drug synergize to kill cancer cells. Neoplasia 11, 1165–1173 (2009).
Delie, F., Petignat, P. & Cohen, M. GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78. Target. Oncol. 8, 225–230 (2013).
Elfiky, A. A., Baghdady, A. M., Ali, S. A. & Ahmed, M. I. GRP78 targeting: hitting two birds with a stone. Life Sci. 260, 118317 (2020).
Mandelin, J. et al. Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors. Proc. Natl Acad. Sci. USA 112, 3776–3781 (2015).
Ferrara, F. et al. Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer. Proc. Natl Acad. Sci. USA 113, 12786–12791 (2016).
Burikhanov, R. et al. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 138, 377–388 (2009).
Zhang, X. et al. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer. Drug Des. Devel. Ther. 13, 1357–1372 (2019).
Hoter, A., Rizk, S. & Naim, H. Y. The multiple roles and therapeutic potential of molecular chaperones in prostate cancer. Cancers https://doi.org/10.3390/cancers11081194 (2019).
Eccles, S. A. et al. NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res. 68, 2850–2860 (2008).
Rocchi, P. et al. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer. Cancer Res. 64, 6595–6602 (2004).
Rocchi, P. et al. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Res. 65, 11083–11093 (2005).
Solit, D. B. et al. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin. Cancer Res. 8, 986–993 (2002).
Saporita, A. J., Ai, J. & Wang, Z. The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells. Prostate 67, 509–520 (2007).
He, S. et al. Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression. Int. J. Oncol. 42, 35–43 (2013).
Thakur, M. K. et al. A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC) — a prostate cancer clinical trials consortium (PCCTC) study. Invest. New Drugs 34, 112–118 (2016).
Moon, S. J. et al. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. Theranostics 11, 958–973 (2021).
Rocchi, P. et al. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. BJU Int. 98, 1082–1089 (2006).
Kumano, M. et al. Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer. Mol. Cancer Ther. 11, 1661–1671 (2012).
Yu, E. Y. et al. A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer. Invest. N. Drugs 36, 278–287 (2018).
Lamoureux, F. et al. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer. Eur. Urol. 66, 145–155 (2014).
Maly, D. J. & Papa, F. R. Druggable sensors of the unfolded protein response. Nat. Chem. Biol. 10, 892–901 (2014).
Ri, M. et al. Identification of toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood Cancer J. 2, e79 (2012).
Sanches, M. et al. Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors. Nat. Commun. 5, 4202 (2014).
Atkins, C. et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 73, 1993–2002 (2013).
Marciniak, S. J., Chambers, J. E. & Ron, D. Pharmacological targeting of endoplasmic reticulum stress in disease. Nat. Rev. Drug Discov. https://doi.org/10.1038/s41573-021-00320-3 (2021).
Sidrauski, C. et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. Elife 2, e00498 (2013).
Rabouw, H. H. et al. Small molecule ISRIB suppresses the integrated stress response within a defined window of activation. Proc. Natl Acad. Sci. USA 116, 2097–2102 (2019).
Maltais, R. et al. Induction of endoplasmic reticulum stress-mediated apoptosis by aminosteroid RM-581 efficiently blocks the growth of PC-3 cancer cells and tumors resistant or not to docetaxel. Int. J. Mol. Sci. https://doi.org/10.3390/ijms222011181 (2021).
Tan, B., Jia, R., Wang, G. & Yang, J. Astragaloside attenuates the progression of prostate cancer cells through endoplasmic reticulum stress pathways. Oncol. Lett. 16, 3901–3906 (2018).
Cai, J. et al. A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers. Oncotarget 8, 63232–63246 (2017).
Kobylewski, S. E., Henderson, K. A., Yamada, K. E. & Eckhert, C. D. Activation of the EIF2alpha/ATF4 and ATF6 pathways in DU-145 cells by boric acid at the concentration reported in men at the US mean boron intake. Biol. Trace Elem. Res. 176, 278–293 (2017).
Sanchez, A. M. et al. Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem. Biophys. Res. Commun. 372, 785–791 (2008).
Evelyn, C. R. et al. Small-molecule inhibition of Rho/MKL/SRF transcription in prostate cancer cells: modulation of cell cycle, ER stress, and metastasis gene networks. Microarrays https://doi.org/10.3390/microarrays5020013 (2016).
Wang, W. B. et al. Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J. Cell Physiol. 227, 2196–2206 (2012).
Kim, H. K. et al. Chalcone suppresses tumor growth through NOX4-IRE1α sulfonation-RIDD-miR-23b axis. Redox Biol. 40, 101853 (2021).
Wu, S. et al. Chelerythrine induced cell death through ROS-dependent ER stress in human prostate cancer cells. Onco Targets Ther. 11, 2593–2601 (2018).
Ryu, S., Lim, W., Bazer, F. W. & Song, G. Chrysin induces death of prostate cancer cells by inducing ROS and ER stress. J. Cell Physiol. 232, 3786–3797 (2017).
Fan, L. et al. Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways. Cancer Manag. Res. 10, 4817–4829 (2018).
Wang, M. et al. Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer. Br. J. Pharmacol. 171, 4478–4489 (2014).
Ma, B. et al. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. J. Exp. Clin. Cancer Res. 37, 210 (2018).
Lee, W. J. et al. Nonautophagic cytoplasmic vacuolation death induction in human PC-3M prostate cancer by curcumin through reactive oxygen species -mediated endoplasmic reticulum stress. Sci. Rep. 5, 10420 (2015).
Rivera, M. et al. Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells. PLoS ONE 12, e0179587 (2017).
Pak, S. et al. The small molecule WNT/beta-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J. Exp. Clin. Cancer Res. 38, 342 (2019).
Nawasreh, M. M. et al. Biological activity and apoptotic signaling pathway of C11-functionalized cephalostatin 1 analogues. Steroids 158, 108602 (2020).
Yang, D. L. et al. Demethylzeylasteral (T-96) initiates extrinsic apoptosis against prostate cancer cells by inducing ROS-mediated ER stress and suppressing autophagic flux. Biol. Res. 54, 27 (2021).
Sun, S. et al. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress. Chaperones 9, 76–87 (2004).
Sanchez, M. et al. Oxidized analogs of Di(1H-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity. Oncotarget 9, 25057–25074 (2018).
Matsumoto, T. et al. Doxycycline induces apoptosis via ER stress selectively to cells with a cancer stem cell-like properties: importance of stem cell plasticity. Oncogenesis 6, 397 (2017).
Tao, T. et al. Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress. Biochem. Biophys. Res. Commun. 503, 2685–2689 (2018).
Sapili, H., Ho, C. S., Malagobadan, S., Arshad, N. M. & Nagoor, N. H. Geranylated 4-phenylcoumarins extracted from Mesua elegans induced caspase-independent cell death in prostate cancer cell lines through calpain-2 and cathepsin B. Sci. Rep. 10, 986 (2020).
Sun, C., Chesnokov, V., Larson, G. & Itakura, K. Glucosamine enhances TRAIL-induced apoptosis in the prostate cancer cell line DU145. Medicines https://doi.org/10.3390/medicines6040104 (2019).
Lee, M. G. et al. Heteronemin, a marine sesterterpenoid-type metabolite, induces apoptosis in prostate LNcap cells via oxidative and ER stress combined with the inhibition of topoisomerase II and Hsp90. Mar. Drugs https://doi.org/10.3390/md16060204 (2018).
Huang, H. et al. Isoalantolactone increases the sensitivity of prostate cancer cells to cisplatin treatment by inducing oxidative stress. Front. Cell Dev. Biol. 9, 632779 (2021).
Chen, W. et al. Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells. J. Exp. Clin. Cancer Res. 37, 309 (2018).
Li, K. et al. Isobavachalcone induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in human prostate cancer PC-3 cells. Oxid. Med. Cell Longev. 2018, 1915828 (2018).
Kim, M. J. et al. In vitro anticancer effects of JI017 on two prostate cancer cell lines involve endoplasmic reticulum stress mediated by elevated levels of reactive oxygen species. Front. Pharmacol. 12, 683575 (2021).
Gafar, A. A. et al. Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells. PeerJ 4, e2445 (2016).
Lin, H. Y. et al. The anti-proliferative activity of secondary metabolite from the marine streptomyces sp. against prostate cancer cells. Life https://doi.org/10.3390/life11121414 (2021).
Li, G., Petiwala, S. M., Pierce, D. R., Nonn, L. & Johnson, J. J. Selective modulation of endoplasmic reticulum stress markers in prostate cancer cells by a standardized mangosteen fruit extract. PLoS ONE 8, e81572 (2013).
Jiang, H. et al. Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells. Cell Death Dis. 4, e761 (2013).
Zhang, T. W., Xing, L., Tang, J. L., Lu, J. X. & Liu, C. X. Marchantin M induces apoptosis of prostate cancer cells through endoplasmic reticulum stress. Med. Sci. Monit. 21, 3570–3576 (2015).
Chang, J. et al. Matrine inhibits prostate cancer via activation of the unfolded protein response/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transition. Mol. Med. Rep. 18, 945–957 (2018).
Afolabi, S. O. et al. Polyalthia longifolia extract triggers ER stress in prostate cancer cells concomitant with induction of apoptosis: insights from in vitro and in vivo studies. Oxid. Med. Cell Longev. 2019, 6726312 (2019).
Chiu, H. W. et al. Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy. PLoS ONE 7, e40462 (2012).
Burton, L. J. et al. Muscadine grape skin extract induces an unfolded protein response-mediated autophagy in prostate cancer cells: a TMT-based quantitative proteomic analysis. PLoS ONE 11, e0164115 (2016).
Chiu, S. C. et al. Induction of apoptosis coupled to endoplasmic reticulum stress in human prostate cancer cells by n-butylidenephthalide. PLoS ONE 7, e33742 (2012).
Guan, M., Su, L., Yuan, Y. C., Li, H. & Chow, W. A. Nelfinavir and nelfinavir analogs block site-2 protease cleavage to inhibit castration-resistant prostate cancer. Sci. Rep. 5, 9698 (2015).
Wu, M. H. et al. Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression. Env. Toxicol. 36, 2206–2216 (2021).
Wang, L. et al. Dissociation of NSC606985 induces atypical ER-stress and cell death in prostate cancer cells. Int. J. Oncol. 49, 529–538 (2016).
Chang, Y. M. et al. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Env. Toxicol. 34, 1329–1339 (2019).
Huang, H. et al. Plumbagin triggers ER stress-mediated apoptosis in prostate cancer cells via induction of ROS. Cell Physiol. Biochem. 45, 267–280 (2018).
Rizzi, F. et al. Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis. Carcinogenesis 35, 828–839 (2014).
Wang, F. et al. Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress. Cell Cycle 19, 541–550 (2020).
Huong, P. T. et al. Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression. Cell Signal. 23, 857–865 (2011).
Zhang, X. et al. Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production. Onco Targets Ther. 13, 513–523 (2020).
Selvaraj, S., Sun, Y., Sukumaran, P. & Singh, B. B. Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Mol. Carcinog. 55, 818–831 (2016).
Yu, J., Yang, Y., Li, S. & Meng, P. Salinomycin triggers prostate cancer cell apoptosis by inducing oxidative and endoplasmic reticulum stress via suppressing Nrf2 signaling. Exp. Ther. Med. 22, 946 (2021).
Zhang, Y. et al. Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells. BMC Cancer 19, 381 (2019).
Gara, R. K. et al. Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway. J. Biomed. Sci. 22, 26 (2015).
Kim, S. H. et al. Silibinin induces mitochondrial NOX4-mediated endoplasmic reticulum stress response and its subsequent apoptosis. BMC Cancer 16, 452 (2016).
Song, J. H. & Kraft, A. S. Pim kinase inhibitors sensitize prostate cancer cells to apoptosis triggered by Bcl-2 family inhibitor ABT-737. Cancer Res. 72, 294–303 (2012).
Nagesh, P. K. B. et al. Tannic acid induces endoplasmic reticulum stress-mediated apoptosis in prostate cancer. Cancers https://doi.org/10.3390/cancers10030068 (2018).
Chiu, S. C. et al. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo. Prostate Cancer Prostatic Dis. 16, 315–322 (2013).
Grayson, K. A., Hope, J. M., Wang, W., Reinhart-King, C. A. & King, M. R. Taxanes sensitize prostate cancer cells to TRAIL-induced apoptotic synergy via endoplasmic reticulum stress. Mol. Cancer Ther. 20, 833–845 (2021).
Xu, Q. et al. Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A. J. Cell Mol. Med. 22, 1909–1922 (2018).
Zhao, F. et al. Triptolide induces protective autophagy through activation of the CaMKKβ-AMPK signaling pathway in prostate cancer cells. Oncotarget 7, 5366–5382 (2016).
Yang, J. B. et al. Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro. Acta Pharmacol. Sin. 37, 950–962 (2016).
Bruno, R. D., Gover, T. D., Burger, A. M., Brodie, A. M. & Njar, V. C. 17α-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. Mol. Cancer Ther. 7, 2828–2836 (2008).
Chen, H. et al. A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growth. Cancer Lett. 532, 215580 (2022).
Hessenauer, A., Schneider, C. C., Gotz, C. & Montenarh, M. CK2 inhibition induces apoptosis via the ER stress response. Cell Signal. 23, 145–151 (2011).
Hsieh, C. L. et al. A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway. Mol. Cancer Ther. 19, 101–111 (2020).
Fontana, F. et al. δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells. Cell Prolif. 52, e12576 (2019).